<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23573189</article-id><article-id pub-id-type="pmc">3613423</article-id><article-id pub-id-type="publisher-id">PONE-D-12-19687</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0058272</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology</subject><subj-group><subject>Population Biology</subject><subj-group><subject>Epidemiology</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine</subject><subj-group><subject>Clinical Research Design</subject><subj-group><subject>Epidemiology</subject></subj-group></subj-group><subj-group><subject>Diagnostic Medicine</subject><subj-group><subject>Test Evaluation</subject></subj-group></subj-group><subj-group><subject>Epidemiology</subject><subj-group><subject>Clinical Epidemiology</subject></subj-group></subj-group><subj-group><subject>Nutrition</subject><subj-group><subject>Obesity</subject></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Percentage of Body Fat Assessment Using Bioelectrical Impedance Analysis and Dual-Energy X-ray Absorptiometry in a Weight Loss Program for Obese or Overweight Chinese Adults</article-title><alt-title alt-title-type="running-head">Validity of BIA for Percentage of Body Fat</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Li</surname><given-names>Yi-Chun</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Li</surname><given-names>Chia-Ing</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Lin</surname><given-names>Wen-Yuan</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref><xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Chiu-Shong</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref><xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Hsu</surname><given-names>Hua-Shui</given-names></name><xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Cheng-Chun</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref><xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Fei-Na</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Tsai-Chung</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Lin</surname><given-names>Cheng-Chieh</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref><xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref></contrib></contrib-group><aff id="aff1">
<label>1</label>
<addr-line>Graduate Institute of Biostatistics, College of Public Health, China Medical University, Taichung, Taiwan</addr-line>
</aff><aff id="aff2">
<label>2</label>
<addr-line>School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan</addr-line>
</aff><aff id="aff3">
<label>3</label>
<addr-line>Department of Medical Research, China Medical University Hospital, Taichung, Taiwan</addr-line>
</aff><aff id="aff4">
<label>4</label>
<addr-line>Department of Family Medicine, China Medical University Hospital, Taichung, Taiwan</addr-line>
</aff><aff id="aff5">
<label>5</label>
<addr-line>Department of Neurology, China Medical University Hospital, Taichung, Taiwan</addr-line>
</aff><aff id="aff6">
<label>6</label>
<addr-line>Institute of Health Care Administration, College of Health Science, Asia University, Taichung, Taiwan</addr-line>
</aff><contrib-group><contrib contrib-type="editor"><name><surname>Behrens</surname><given-names>Thomas</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">
<addr-line>Universit&#x000e4;t Bochum, Germany</addr-line>
</aff><author-notes><corresp id="cor1">* E-mail: <email>cclin@mail.cmuh.org.tw</email> (C-CL); <email>tcli@mail.cmu.edu.tw</email> (T-CL); <email>feina@mail.cmu.edu.tw</email> (F-NC)</corresp><fn fn-type="COI-statement"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="con"><p>Conceived and designed the experiments: TCL. Performed the experiments: YCL TCL HSH. Analyzed the data: TCL YCL. Contributed reagents/materials/analysis tools: FNC CIL CSL WYL CCL. Wrote the paper: YCL FNC.</p></fn></author-notes><pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="epub"><day>1</day><month>4</month><year>2013</year></pub-date><volume>8</volume><issue>4</issue><elocation-id>e58272</elocation-id><history><date date-type="received"><day>9</day><month>7</month><year>2012</year></date><date date-type="accepted"><day>5</day><month>2</month><year>2013</year></date></history><permissions><copyright-statement>&#x000a9; 2013 Li et al</copyright-statement><copyright-year>2013</copyright-year><copyright-holder>Li et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p></license></permissions><abstract><p>The current study aimed to compare the estimates of body fat percentage (%BF) by performing bioelectrical impedance analysis (BIA) and dual energy X-ray absorptiometry (DXA) in a sample of obese or overweight Chinese adults who participated in a weight-loss randomized control trial stratified by gender to determine whether or not BIA is a valid measurement tool. Among 189 adults [73 males, 116 females; age &#x0200a;=&#x0200a;41 to 74 years; mean body mass index (BMI) &#x0200a;=&#x0200a;27.3 kg/m<sup>2</sup>], assessments of %BF at the baseline and six months from the baseline were conducted by performing BIA and DXA. Bland-Altman analyses and multiple regression analyses were used to assess the relationships between %BF<sub>BIA</sub> and %BF<sub>DXA</sub>. Compared with DXA, BIA underestimated %BF [in males: 4.6, &#x02013;2.4 to 11.7 (mean biases, 95% limit of agreement) at the baseline, 1.4, &#x02013;7.4 to 10.2 at the endpoint, and 3.2, &#x02013;4.8 to 11.3 in changes; in females: 5.1, &#x02013;2.4 to 12.7; 2.2, &#x02013;6.1 to 10.4; and 3.0, &#x02013;4.8 to 10.7, respectively]. For males and females, %BFDXA proved to be a significant predictor of the difference between DXA and BIA at the baseline, the endpoint, and in changes when BMI and age were considered (in males: p&#x0003c;0.01 and <italic>R</italic>
<sup>2</sup> &#x0200a;=&#x0200a;23.1%, 24.1%, 20.7%, respectively; for females: p&#x0003c;0.001 and <italic>R</italic>
<sup>2</sup> &#x0200a;=&#x0200a;40.4%, 48.8%, 25.4%, respectively). The current study suggests that BIA provides a relatively accurate prediction of %BF in individuals with normal weight, overweight, or obesity after the end of weight-loss program, but less accurate prediction of %BF in obese individuals at baseline or weight change during the weight-loss intervention program.</p></abstract><funding-group><funding-statement>This study was supported by grants from the National Science Council of Taiwan (NSC93-2314-B-039-025 &#x00026; NSC94-2314-B-039-024 &#x00026; NSC96-2628-B-039-011-MY3), the Department of Health, Executive Yuan, Taiwan (DOH97-TD-F-113-96002), the Taiwan Department of Health Clinical Trial and Research Center for Excellence (DOH102-TD-B-111-004), the National Science Council of Taiwan (<ext-link ext-link-type="uri" xlink:href="http://web1.nsc.gov.tw/mp.aspx?mp=7">http://web1.nsc.gov.tw/mp.aspx?mp=7</ext-link>), and the Department of Health, Executive Yuan, Taiwan (<ext-link ext-link-type="uri" xlink:href="http://www.doh.gov.tw/EN2006/index_EN.aspx">http://www.doh.gov.tw/EN2006/index_EN.aspx</ext-link>. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="7"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Obesity is a major global health problem, which affects people in developed and developing countries <xref rid="pone.0058272-Kannel1" ref-type="bibr">[1]</xref>&#x02013;<xref rid="pone.0058272-Consultation1" ref-type="bibr">[4]</xref>. Approximately 250 million adults suffer from obesity <xref rid="pone.0058272-Kuczmarski1" ref-type="bibr">[5]</xref>, <xref rid="pone.0058272-Seidell1" ref-type="bibr">[6]</xref>. According to surveys, the age-adjusted prevalence of obesity for males is rapidly increasing in Taiwan from 10.5% to 15.9% from 1993 to 1996 and from 2000 to 2001 <xref rid="pone.0058272-Chu1" ref-type="bibr">[7]</xref>. Obesity is also associated with numerous chronic health conditions or diseases, such as diabetes, hypertension, and cardiovascular diseases <xref rid="pone.0058272-Must1" ref-type="bibr">[8]</xref>, <xref rid="pone.0058272-Kopelman1" ref-type="bibr">[9]</xref>.</p><p>The commonly used indicators for obesity are body mass index (BMI), waist circumference (WC), waist-height ratio (WHtR), and waist-to-hip ratio (WHR). Bioelectrical impedance analysis (BIA) produces a close estimate of fat mass in a wide range of body compositions <xref rid="pone.0058272-Deurenberg1" ref-type="bibr">[10]</xref>. BIA is a non-invasive measurement of body composition and particularly useful in large epidemiologic studies. BIA has also many advantages compared with other methods because it is inexpensive, simple, fast, safe, portable, and easy to perform, as well as requires minimum operator training <xref rid="pone.0058272-Houtkooper1" ref-type="bibr">[11]</xref>, <xref rid="pone.0058272-Roubenoff1" ref-type="bibr">[12]</xref>. Instead of using the common indicators for obesity such as BMI, WC, WHtR, and WHR, BIA is used to determine the body fat percentage (%BF). Other obesity indicators do not measure %BF because of their inability to distinguish fat from muscle. For instance, a study has found that adiponectin, a substance secreted by the adipose tissue, can regulate energy homeostasis as well as glucose and lipid metabolism <xref rid="pone.0058272-Yamauchi1" ref-type="bibr">[13]</xref>. Adiponectin is also involved in inhibiting inflammatory responses through its inhibitory functions <xref rid="pone.0058272-Yokota1" ref-type="bibr">[14]</xref>. Another study has revealed that adiponectin is also associated with body fat distribution <xref rid="pone.0058272-Staiger1" ref-type="bibr">[15]</xref>, even in normal-weight subjects <xref rid="pone.0058272-Festen1" ref-type="bibr">[16]</xref>. Furthermore, %BF is more effective in detecting individuals with disturbed glucose tolerance, risk of cardiometabolic disease, early stage cardiovascular disease, and breast cancer survival rate <xref rid="pone.0058272-GmezAmbrosi1" ref-type="bibr">[17]</xref>&#x02013;<xref rid="pone.0058272-Dee1" ref-type="bibr">[20]</xref>. Thus, %BF should be determined.</p><p>A previous study confirmed the validity of BIA in estimating %BF compared with dual-energy X-ray absorptiometry (DXA) <xref rid="pone.0058272-Roubenoff1" ref-type="bibr">[12]</xref>. DXA is a valid method to aid studies on obesity <xref rid="pone.0058272-Evans1" ref-type="bibr">[21]</xref>. However, radiation emitted during DXA measure has been reported in previous studies <xref rid="pone.0058272-DeSchepper1" ref-type="bibr">[22]</xref>&#x02013;<xref rid="pone.0058272-Xu1" ref-type="bibr">[24]</xref>. The effective radiation dose of DXA is among the lowest from the commonly used medical X-ray examinations and lower than a standard chest X-ray <xref rid="pone.0058272-DeSchepper1" ref-type="bibr">[22]</xref>. Therefore, DXA is appropriate for clinical patient treatment; however, unlike BIA, DXA limits epidemiological studies and wide application. BIA is a good predictor of DXA-derived fat-free mass (<italic>r</italic>&#x0200a;=&#x0200a;0.85 to 0.88) <xref rid="pone.0058272-Roubenoff1" ref-type="bibr">[12]</xref>. BIA measurements are determined by the resistance of the body to electrical current flow between points of contact on the body and correlates well with total body water measurements <xref rid="pone.0058272-Erceg1" ref-type="bibr">[25]</xref>. BIA exhibits greater resistance to electrical current flow in fat tissues than fat-free tissues because of their differences in water content.</p><p>Several studies have been conducted on the validation of BIA in the estimation of %BF compared with DXA <xref rid="pone.0058272-Roubenoff1" ref-type="bibr">[12]</xref>, <xref rid="pone.0058272-Lazzer1" ref-type="bibr">[26]</xref>&#x02013;<xref rid="pone.0058272-Kim1" ref-type="bibr">[36]</xref>. However, only two %BF studies, in which BIA was used, has been conducted among Asian adults. One study <xref rid="pone.0058272-Sato1" ref-type="bibr">[29]</xref> involves a cross-sectional investigation stratified by gender and the other <xref rid="pone.0058272-Kim1" ref-type="bibr">[36]</xref> uses a longitudinal study on Korean women. Most of the studies have been conducted on Caucasians <xref rid="pone.0058272-Lazzer1" ref-type="bibr">[26]</xref>, <xref rid="pone.0058272-Shafer1" ref-type="bibr">[28]</xref>, <xref rid="pone.0058272-Verdich1" ref-type="bibr">[30]</xref>&#x02013;<xref rid="pone.0058272-Neovius1" ref-type="bibr">[32]</xref>, <xref rid="pone.0058272-LloretLinares1" ref-type="bibr">[34]</xref> and African-Americans <xref rid="pone.0058272-Newton1" ref-type="bibr">[27]</xref>, <xref rid="pone.0058272-NewtonJr1" ref-type="bibr">[33]</xref>. Several studies have considered only women <xref rid="pone.0058272-Newton1" ref-type="bibr">[27]</xref>, <xref rid="pone.0058272-Verdich1" ref-type="bibr">[30]</xref>, <xref rid="pone.0058272-Neovius1" ref-type="bibr">[32]</xref>, <xref rid="pone.0058272-NewtonJr1" ref-type="bibr">[33]</xref>, <xref rid="pone.0058272-Kim1" ref-type="bibr">[36]</xref> or adolescents <xref rid="pone.0058272-Lazzer1" ref-type="bibr">[26]</xref>, <xref rid="pone.0058272-Newton1" ref-type="bibr">[27]</xref>. Longitudinal studies <xref rid="pone.0058272-Verdich1" ref-type="bibr">[30]</xref>, <xref rid="pone.0058272-LloretLinares1" ref-type="bibr">[34]</xref>&#x02013;<xref rid="pone.0058272-Frisard1" ref-type="bibr">[37]</xref> have also been performed, in which two studies have used weight-loss programs without randomization <xref rid="pone.0058272-LloretLinares1" ref-type="bibr">[34]</xref>, <xref rid="pone.0058272-Kim1" ref-type="bibr">[36]</xref>. The sample sizes used in most of these studies are small, which range from 53 to 136 subjects <xref rid="pone.0058272-Lazzer1" ref-type="bibr">[26]</xref>&#x02013;<xref rid="pone.0058272-Sato1" ref-type="bibr">[29]</xref>, <xref rid="pone.0058272-BosyWestphal1" ref-type="bibr">[31]</xref>&#x02013;<xref rid="pone.0058272-NewtonJr1" ref-type="bibr">[33]</xref>. Only two studies have considered a large sample size (<italic>n</italic>&#x0003e;500) <xref rid="pone.0058272-Roubenoff1" ref-type="bibr">[12]</xref>, <xref rid="pone.0058272-LloretLinares1" ref-type="bibr">[34]</xref>. The sample sizes of previous longitudinal studies <xref rid="pone.0058272-Verdich1" ref-type="bibr">[30]</xref>, <xref rid="pone.0058272-LloretLinares1" ref-type="bibr">[34]</xref>&#x02013;<xref rid="pone.0058272-Frisard1" ref-type="bibr">[37]</xref> ranged from 34 to 105 subjects. The validation of the hand-to-foot BIA with simple frequency is also limited <xref rid="pone.0058272-Sato1" ref-type="bibr">[29]</xref>, <xref rid="pone.0058272-Neovius1" ref-type="bibr">[32]</xref>.</p><p>Addressing questions on whether or not BIA is a valid method for monitoring the changes in %BF to evaluate the effects of weight-loss programs is highly important because of the increasing need for an administrable and accurate instrument in weight-loss programs.</p><p>The current study aimed to compare estimates of %BF by performing BIA and DXA in a sample of obese or overweight Chinese adults who participated in a weight-loss intervention trial in Taiwan. This study also determined whether or not BIA is a valid measurement tool for weight-loss programs.</p></sec><sec sec-type="materials|methods" id="s2"><title>Materials and Methods</title><sec id="s2a"><title>Subjects</title><p>The study population consisted of obese or overweight individuals who are in good health and reside in the Taichung city, which is located in west-central Taiwan. Data were collected from participants of a randomized intervention study, in which the effects of three weight-loss programs were evaluated. The duration of the intervention programs was six months. Assessments were made at the baseline and six months from the baseline. The subjects were recruited during community screening activities, advertisements, and Internet propaganda. Before randomization, 240 obese or overweight adults (age &#x0003e;40 years) at the baseline were recruited according to either one of the two criteria of obesity: (1) BMI recommended by the Department of Health, Executive Yuan, R.O.C <xref rid="pone.0058272-Department1" ref-type="bibr">[38]</xref> and (2) WC recommended by an Asian modification for the (central) obesity by National Cholesterol Education program Adult Treatment Panel-III (NCEP ATP-III) definition of metabolic syndrome (MetS) <xref rid="pone.0058272-Crepaldi1" ref-type="bibr">[39]</xref>. The BMI cut-off points for obese and overweight were 27&#x000a0;and 24 kg/m<sup>2</sup>, respectively. The WC cut-off points for (central) obesity were 90 and 80 cm in males and females, respectively. Under this condition, several subjects with (central) obesity determined by WC at the baseline may have a normal BMI. Complete data included 189 subjects (73 males and 116 females); 51 subjects were removed because of missing or incomplete data at the end of the study. The study was approved by the Human Research Committee of the China Medical University Hospital. Written informed consent was obtained from each participant.</p></sec><sec id="s2b"><title>Anthropometric measurements</title><p>Weight and height were measured using an auto-anthropometer (Super-View, HW-666, Taipei, Taiwan) and estimated to the nearest 0.1 kg and 0.1 cm, respectively (the subjects were shoeless and wore light clothing). BMI was calculated as weight (kg) divided by the square of height (m). %BF was determined by performing BIA and DXA.</p></sec><sec id="s2c"><title>BIA</title><p>A body composition analyzer (Tanita BC-418, Tanita Corp., Tokyo, Japan) was used to estimate %BF. Eight polar electrodes were applied on both feet and both hands. The electric current was then supplied from the electrodes on the tips of the toes and fingers and the voltage was measured on the heel of both feet and the thenar side of both hands. The analyzer provided a complete %BF analysis, including %BF, in less than 30 s. The analyzer can be used for subjects with weights of up to 200 kg and measure the body composition by using a constant current source at a frequency current of 50 kHz (500 &#x000b5;&#x000c5;). Before the assessment, the participants were subjected to a 12 h fasting period and instructed to avoid heavy physical activity, alcohol ingestion, and diuretic intake. After the assessors manually documented the weight of clothes, body type, age, and height into the system, the subjects in light clothing removed their shoes, wiped their feet, and stood on the weighing platform without bending their knees. Measurement began when the subjects placed their hands on the grips. Thereafter, the process was completed. The BIA variable used in the present study was %BF<sub>BIA</sub>.</p></sec><sec id="s2d"><title>DXA</title><p>Fat mass was measured using DXA (GE-LUNAR DPX PRO, Lunar Corp., Madison, WI, USA). Data were analyzed using the enCORE2004 software, version 8.60.006 at coefficient of variation &#x0003c;1%. The subjects were subjected to DXA in their underwear, without any metal items. The operator performed a whole-body scan on each subject as he/she lies in a supine position. Whole-body composition analysis provided data on different regions of interest, including the trunk, arms, and legs. Equipment was calibrated each day by using a standardized phantom. The DXA variable used in the present study was %BF<sub>DXA</sub>.</p></sec><sec id="s2e"><title>Statistical analysis</title><p>Descriptive data at the baseline, the endpoint, and in changes stratified by gender were presented as mean (SD). The methods used to assess the relationships between %BF<sub>BIA</sub> and %BF<sub>DXA</sub> stratified by gender at different stages were Pearson's correlation coefficients (<italic>r</italic>), Bland-Altman analyses, and multiple regression analyses. <italic>r</italic> among BMI, %BF<sub>BIA</sub>, and %BF<sub>DXA</sub> were also calculated. The level of correlation was considered low or weak when <italic>r</italic>&#x02264;0.35, moderate when <italic>r</italic>&#x0200a;=&#x0200a;0.36 to 0.67, and strong when <italic>r</italic>&#x0200a;=&#x0200a;0.68 to 1.0 <xref rid="pone.0058272-Taylor1" ref-type="bibr">[40]</xref>. The mean bias and 95% limits of agreement between %BF<sub>BIA</sub> and %BF<sub>DXA</sub> were estimated in the Bland-Altman plots and reported by table, with the %BF<sub>DXA</sub> as the gold standard and %BF<sub>BIA</sub> as the comparison. Stepwise multiple regression analyses were used to identify the significant predictors of differences between %BF<sub>BIA</sub> and %BF<sub>DXA</sub>. A significant explanatory variable for this difference indicates that the measurement error systematically varied according to the values of this explanatory variable. Thus, the measurement errors were associated with this explanatory variable. Under this condition, the explanatory variable is a measurement bias. However, an explanatory variable is not a significant predictor, indicating that the measurement error is random according to this explanatory variable. The higher <italic>R</italic>
<sup>2</sup> and the greater magnitude of the difference between %BF<sub>BIA</sub> and %BF<sub>DXA</sub> can be explained by the explanatory variables. The first model includes %BF<sub>DXA</sub>, whereas the second model considers %BF<sub>DXA</sub>, BMI, and age. All of the analyses were performed using SAS version 9.2 (SAS Institute, Cary, North Carolina). All two-sided p-values &#x0003c;0.05 were considered statistically significant.</p></sec></sec><sec id="s3"><title>Results</title><sec id="s3a"><title>Study subject characteristics</title><p>
<xref ref-type="table" rid="pone-0058272-t001">Table 1</xref> presents the baseline characteristics and the subjects' subsequent changes by gender. Their ages ranged from 41 to 74 years. Based on BMI, male subjects who were obese, overweight, and had normal weight at the baseline were 46.6%, 52.1%, and 1.4%, respectively. In females, the corresponding percentages were 38.8%, 50.9%, and 10.3%, respectively. Females had a higher percentage of total body fat in BIA and DXA. During the intervention period, decreases in weight, BMI, and %BF<sub>DXA</sub> were observed, but a slight increase in %BF was found in BIA at the endpoint. After the intervention program, 13.76% of the subjects had normal weight, in which eight were male and eight were female. For both males and females, BIA underestimated %BF with the greatest difference at the baseline and the least difference at the endpoint.</p><table-wrap id="pone-0058272-t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0058272.t001</object-id><label>Table 1</label><caption><title>Subject characteristics.</title></caption><alternatives><graphic id="pone-0058272-t001-1" xlink:href="pone.0058272.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Gender</td><td align="left" rowspan="1" colspan="1">Variable</td><td align="left" rowspan="1" colspan="1">Baseline</td><td align="left" rowspan="1" colspan="1">Endpoint</td><td align="left" rowspan="1" colspan="1">Change</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<bold>Male</bold>
</td><td align="left" rowspan="1" colspan="1">AGE (year)</td><td align="left" rowspan="1" colspan="1">52.8(7.0)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">(n&#x0200a;=&#x0200a;73)</td><td align="left" rowspan="1" colspan="1">HEIGHT (cm)</td><td align="left" rowspan="1" colspan="1">68.0(6.0)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">WEIGHT (kg)</td><td align="left" rowspan="1" colspan="1">78.3(10.3)</td><td align="left" rowspan="1" colspan="1">76.5(10.6)</td><td align="left" rowspan="1" colspan="1">1.9(2.8)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td align="left" rowspan="1" colspan="1">27.7(2.6)</td><td align="left" rowspan="1" colspan="1">27.0(2.7)</td><td align="left" rowspan="1" colspan="1">0.68(1.1)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">%BF<sub>BIA</sub> (%)</td><td align="left" rowspan="1" colspan="1">25.3(4.4)</td><td align="left" rowspan="1" colspan="1">26.8(5.8)</td><td align="left" rowspan="1" colspan="1">&#x02212;1.5(4.7)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">%BF<sub>DXA</sub> (%)</td><td align="left" rowspan="1" colspan="1">29.9(3.4)</td><td align="left" rowspan="1" colspan="1">28.1(4.5)</td><td align="left" rowspan="1" colspan="1">1.7(2.6)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x00394;%BF (%)</td><td align="left" rowspan="1" colspan="1">4.6(3.6)</td><td align="left" rowspan="1" colspan="1">1.4(4.5)</td><td align="left" rowspan="1" colspan="1">3.2(4.1)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">MEAN %BF (%)</td><td align="left" rowspan="1" colspan="1">27.6(3.5)</td><td align="left" rowspan="1" colspan="1">27.4(4.7)</td><td align="left" rowspan="1" colspan="1">0.12(3.2)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">ICC (%BF)</td><td align="left" rowspan="1" colspan="1">0.58</td><td align="left" rowspan="1" colspan="1">0.63</td><td align="left" rowspan="1" colspan="1">0.41</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">
<bold>Female</bold>
</td><td align="left" rowspan="1" colspan="1">AGE (year)</td><td align="left" rowspan="1" colspan="1">52.4(6.9)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">(n&#x0200a;=&#x0200a;116)</td><td align="left" rowspan="1" colspan="1">HEIGHT (cm)</td><td align="left" rowspan="1" colspan="1">155.5(5.5)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">WEIGHT (kg)</td><td align="left" rowspan="1" colspan="1">65.4(8.2)</td><td align="left" rowspan="1" colspan="1">62.7(8.1)</td><td align="left" rowspan="1" colspan="1">2.7(3.4)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td align="left" rowspan="1" colspan="1">27.0(3.0)</td><td align="left" rowspan="1" colspan="1">25.9(3.1)</td><td align="left" rowspan="1" colspan="1">1.1(1.4)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">%BF<sub>BIA</sub> (%)</td><td align="left" rowspan="1" colspan="1">36.6(4.4)</td><td align="left" rowspan="1" colspan="1">37.3(5.5)</td><td align="left" rowspan="1" colspan="1">&#x02212;0.68(4.3)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">%BF<sub>DXA</sub> (%)</td><td align="left" rowspan="1" colspan="1">41.7(4.6)</td><td align="left" rowspan="1" colspan="1">39.4(5.5)</td><td align="left" rowspan="1" colspan="1">2.3(3.2)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x00394;%BF (%)</td><td align="left" rowspan="1" colspan="1">5.1(3.8)</td><td align="left" rowspan="1" colspan="1">2.2(4.2)</td><td align="left" rowspan="1" colspan="1">3.0(4.0)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">MEAN %BF (%)</td><td align="left" rowspan="1" colspan="1">39.1(4.1)</td><td align="left" rowspan="1" colspan="1">38.3(5.1)</td><td align="left" rowspan="1" colspan="1">0.80(3.2)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">ICC (%BF)</td><td align="left" rowspan="1" colspan="1">0.64</td><td align="left" rowspan="1" colspan="1">0.71</td><td align="left" rowspan="1" colspan="1">0.45</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt101"><label/><p>Values are mean(SD); BMI, body mass index; %BF, percentage of body fat; DXA.</p></fn><fn id="nt102"><label/><p>dual energy x-ray absorptiometry; BIA, bioelectrical impedance analysis equipment.</p></fn><fn id="nt103"><label/><p>&#x00394;%BF, mean difference between methods (%BFDXA-%BFBIA); MEAN %BF mean of methods (%BFDXA, %BFBIA). ICC, intraclass correlation coefficient.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3b"><title>Agreement between methods</title><p>For males or females, %BF and BMI were significantly correlated (<xref ref-type="table" rid="pone-0058272-t002">Table 2</xref>). Three strong <italic>r</italic> were observed in females, particularly between %BF<sub>BIA</sub> and BMI, between %BF<sub>BIA</sub> and %BF<sub>DXA</sub> at the endpoint, as well as between %BF<sub>DXA</sub> and BMI in changes. Agreement between these methods is shown in <xref ref-type="table" rid="pone-0058272-t003">Table 3</xref> and <xref ref-type="fig" rid="pone-0058272-g001">Figure 1</xref> by using the Bland-Altman plots with mean bias and 95% limits of agreement. For both males and females, the mean differences at the endpoint were the smallest compared with the baseline and in changes (<xref ref-type="table" rid="pone-0058272-t003">Table 3</xref>). The slopes in <xref ref-type="fig" rid="pone-0058272-g001">Figure 1</xref> show that the correlation between the differences in DXA and BIA, as well as the mean %BF measured using both methods was stronger in males than that in females at the baseline, the endpoints, and in change. The lines at the endpoint were more parallel to the <italic>x</italic>-axis than those at the baseline and in changes in males and females. At the endpoint, the magnitude of the underestimation of %BF based on BIA decreased compared with that at the baseline. <xref ref-type="table" rid="pone-0058272-t003">Table 3</xref> shows that the mean difference between %BF<sub>DXA</sub> and %BF<sub>BIA</sub> was larger in females than that in males at the baseline and the endpoint, but slightly smaller in males than that in females at changes. <xref ref-type="table" rid="pone-0058272-t004">Table 4</xref> reveals that the magnitude of difference between %BF<sub>DXA</sub> and %BF<sub>BIA</sub> based on DXA, age, and BMI was greater in females than that in males (<italic>R</italic>
<sup>2</sup>
<sub>female</sub> &#x0200a;=&#x0200a;0.23 vs. <italic>R</italic>
<sup>2</sup>
<sub>male</sub> &#x0200a;=&#x0200a;0.05 at the baseline; <italic>R</italic>
<sup>2</sup>
<sub>female</sub> &#x0200a;=&#x0200a;0.13 vs. <italic>R</italic>
<sup>2</sup>
<sub>male</sub> &#x0200a;=&#x0200a;0.03 at the endpoint; and <italic>R</italic>
<sup>2</sup>
<sub>female</sub> &#x0200a;=&#x0200a;0.09 vs. <italic>R</italic>
<sup>2</sup>
<sub>male</sub> &#x0200a;=&#x0200a;0.01 in change).</p><fig id="pone-0058272-g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0058272.g001</object-id><label>Figure 1</label><caption><title>Bland-Altman plots with mean bias (central line) and 95% limits of agreement for comparing %BF<sub>BIA</sub> and %BF<sub>DXA</sub> at the baseline, endpoint, and in changes.</title><p>The central line represents the mean bias between %BF<sub>BIA</sub> and %BF<sub>DXA</sub>; the outer lines represent 95% limits of agreement.</p></caption><graphic xlink:href="pone.0058272.g001"/></fig><table-wrap id="pone-0058272-t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0058272.t002</object-id><label>Table 2</label><caption><title>Pearson correlation matrix for body fat percentage. and anthropometric variables.</title></caption><alternatives><graphic id="pone-0058272-t002-2" xlink:href="pone.0058272.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td colspan="2" align="left" rowspan="1">Male (n&#x0200a;=&#x0200a;73)</td><td colspan="2" align="left" rowspan="1">Female (n&#x0200a;=&#x0200a;116)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">%BF<sub>BIA</sub>
</td><td align="left" rowspan="1" colspan="1">%BF<sub>DXA</sub>
</td><td align="left" rowspan="1" colspan="1">%BFBIA</td><td align="left" rowspan="1" colspan="1">%BF<sub>DXA</sub>
</td></tr></thead><tbody><tr><td colspan="5" align="left" rowspan="1">Baseline</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI</td><td align="left" rowspan="1" colspan="1">0.61</td><td align="left" rowspan="1" colspan="1">0.54</td><td align="left" rowspan="1" colspan="1">0.65</td><td align="left" rowspan="1" colspan="1">0.59</td></tr><tr><td align="left" rowspan="1" colspan="1">%BF<sub>BIA</sub>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.60</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.64</td></tr><tr><td colspan="5" align="left" rowspan="1">Endpoint</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI</td><td align="left" rowspan="1" colspan="1">0.65</td><td align="left" rowspan="1" colspan="1">0.65</td><td align="left" rowspan="1" colspan="1">0.81</td><td align="left" rowspan="1" colspan="1">0.66</td></tr><tr><td align="left" rowspan="1" colspan="1">%BF<sub>BIA</sub>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.65</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.71</td></tr><tr><td colspan="5" align="left" rowspan="1">Change</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI</td><td align="left" rowspan="1" colspan="1">0.58</td><td align="left" rowspan="1" colspan="1">0.65</td><td align="left" rowspan="1" colspan="1">0.58</td><td align="left" rowspan="1" colspan="1">0.79</td></tr><tr><td align="left" rowspan="1" colspan="1">%BF<sub>BIA</sub>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.48</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">0.47</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt104"><label/><p>All are significant at the p&#x0003c;0.001 level.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pone-0058272-t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0058272.t003</object-id><label>Table 3</label><caption><title>Mean differences and 95% limits of agreement between %BF<sub>BIA</sub> and %BF<sub>DXA</sub> using Bland-Altman analysis.</title></caption><alternatives><graphic id="pone-0058272-t003-3" xlink:href="pone.0058272.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td colspan="2" align="left" rowspan="1">Male (n&#x0200a;=&#x0200a;73)</td><td colspan="2" align="left" rowspan="1">Female (n&#x0200a;=&#x0200a;116)</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Mean difference</td><td align="left" rowspan="1" colspan="1">95% limits of agreement</td><td align="left" rowspan="1" colspan="1">Mean difference</td><td align="left" rowspan="1" colspan="1">95% limits of agreement</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Baseline</td><td align="left" rowspan="1" colspan="1">4.6</td><td align="left" rowspan="1" colspan="1">&#x02212;2.4 to 11.7</td><td align="left" rowspan="1" colspan="1">5.1</td><td align="left" rowspan="1" colspan="1">&#x02212;2.4 to 12.7</td></tr><tr><td align="left" rowspan="1" colspan="1">Endpoint</td><td align="left" rowspan="1" colspan="1">1.4</td><td align="left" rowspan="1" colspan="1">&#x02212;7.4 to 10.2</td><td align="left" rowspan="1" colspan="1">2.2</td><td align="left" rowspan="1" colspan="1">&#x02212;6.1 to 10.4</td></tr><tr><td align="left" rowspan="1" colspan="1">Change</td><td align="left" rowspan="1" colspan="1">3.2</td><td align="left" rowspan="1" colspan="1">&#x02212;4.8 to 11.3</td><td align="left" rowspan="1" colspan="1">3.0</td><td align="left" rowspan="1" colspan="1">&#x02212;4.8 to 10.7</td></tr></tbody></table></alternatives></table-wrap><table-wrap id="pone-0058272-t004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0058272.t004</object-id><label>Table 4</label><caption><title>Regression analysis of the difference between DXA and BIA.</title></caption><alternatives><graphic id="pone-0058272-t004-4" xlink:href="pone.0058272.t004"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">&#x00394;%BF</td><td align="left" rowspan="1" colspan="1">Explanatory variables</td><td align="left" rowspan="1" colspan="1">Parameter Estimate</td><td align="left" rowspan="1" colspan="1">p value</td><td align="left" rowspan="1" colspan="1">R<sup>2</sup>
</td></tr><tr><td colspan="5" align="left" rowspan="1">Male</td></tr><tr><td align="left" rowspan="1" colspan="1">Baseline</td><td align="left" rowspan="1" colspan="1">%BF<sub>DXA</sub>
</td><td align="left" rowspan="1" colspan="1">0.23</td><td align="left" rowspan="1" colspan="1">0.06</td><td align="left" rowspan="1" colspan="1">4.9%</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">%BF<sub>DXA</sub>
</td><td align="left" rowspan="1" colspan="1">0.53</td><td align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td align="left" rowspan="1" colspan="1">23.1%</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">BMI</td><td align="left" rowspan="1" colspan="1">0.72</td><td align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">AGE</td><td align="left" rowspan="1" colspan="1">&#x02212;0.04</td><td align="left" rowspan="1" colspan="1">0.51</td><td align="left" rowspan="1" colspan="1"/></tr></tbody></table><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Endpoint</td><td align="left" rowspan="1" colspan="1">%BF <sub>DXA</sub>
</td><td align="left" rowspan="1" colspan="1">0.18</td><td align="left" rowspan="1" colspan="1">0.13</td><td align="left" rowspan="1" colspan="1">3.3%</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">%BF <sub>DXA</sub>
</td><td align="left" rowspan="1" colspan="1">0.59</td><td align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td align="left" rowspan="1" colspan="1">24.1%</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">BMI</td><td align="left" rowspan="1" colspan="1">&#x02212;0.96</td><td align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">AGE</td><td align="left" rowspan="1" colspan="1">&#x02212;0.16</td><td align="left" rowspan="1" colspan="1">0.02</td><td align="left" rowspan="1" colspan="1"/></tr></tbody></table><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Change</td><td align="left" rowspan="1" colspan="1">%BF <sub>DXA</sub>
</td><td align="left" rowspan="1" colspan="1">0.15</td><td align="left" rowspan="1" colspan="1">0.41</td><td align="left" rowspan="1" colspan="1">0.98%</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">%BF <sub>DXA</sub>
</td><td align="left" rowspan="1" colspan="1">0.72</td><td align="left" rowspan="1" colspan="1">0.002</td><td align="left" rowspan="1" colspan="1">20.7%</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">BMI</td><td align="left" rowspan="1" colspan="1">&#x02212;2.0</td><td align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">AGE</td><td align="left" rowspan="1" colspan="1">0.11</td><td align="left" rowspan="1" colspan="1">0.10</td><td align="left" rowspan="1" colspan="1"/></tr></tbody></table><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td colspan="5" align="left" rowspan="1">Female</td></tr><tr><td align="left" rowspan="1" colspan="1">Baseline</td><td align="left" rowspan="1" colspan="1">%BF <sub>DXA</sub>
</td><td align="left" rowspan="1" colspan="1">0.40</td><td align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td align="left" rowspan="1" colspan="1">22.8%</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">%BF <sub>DXA</sub>
</td><td align="left" rowspan="1" colspan="1">0.65</td><td align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td align="left" rowspan="1" colspan="1">40.4%</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">BMI</td><td align="left" rowspan="1" colspan="1">&#x02212;0.62</td><td align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">AGE</td><td align="left" rowspan="1" colspan="1">0.08</td><td align="left" rowspan="1" colspan="1">0.05</td><td align="left" rowspan="1" colspan="1"/></tr></tbody></table><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Endpoint</td><td align="left" rowspan="1" colspan="1">%BF <sub>DXA</sub>
</td><td align="left" rowspan="1" colspan="1">0.28</td><td align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td align="left" rowspan="1" colspan="1">13.5%</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">%BF <sub>DXA</sub>
</td><td align="left" rowspan="1" colspan="1">0.69</td><td align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td align="left" rowspan="1" colspan="1">48.8%</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">BMI</td><td align="left" rowspan="1" colspan="1">&#x02212;1.1</td><td align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">AGE</td><td align="left" rowspan="1" colspan="1">&#x02212;0.01</td><td align="left" rowspan="1" colspan="1">0.83</td><td align="left" rowspan="1" colspan="1"/></tr></tbody></table><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Change</td><td align="left" rowspan="1" colspan="1">%BF <sub>DXA</sub>
</td><td align="left" rowspan="1" colspan="1">0.38</td><td align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td align="left" rowspan="1" colspan="1">9.4%</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">%BF <sub>DXA</sub>
</td><td align="left" rowspan="1" colspan="1">0.99</td><td align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td align="left" rowspan="1" colspan="1">25.4%</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">BMI</td><td align="left" rowspan="1" colspan="1">&#x02212;1.8</td><td align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">AGE</td><td align="left" rowspan="1" colspan="1">0.08</td><td align="left" rowspan="1" colspan="1">0.11</td><td align="left" rowspan="1" colspan="1"/></tr></tbody></table></alternatives></table-wrap><p>
<xref ref-type="table" rid="pone-0058272-t004">Table 4</xref> also shows the statistical analysis for the regression of the differences between DXA and BIA on explanatory variables at the baseline, the endpoint, and in changes stratified by gender. In males, %BF<sub>DXA</sub> alone was not a significant predictor for &#x00394;%BF at the baseline, the endpoint, and in changes. The corresponding percentages of variation for the differences between DXA and BIA explained by %BF<sub>DXA</sub> were 4.9%, 3.3%, and 0.98% at the baseline, the endpoint, and in changes, respectively. BMI and age resulted in significant %BF<sub>DXA</sub> in all of the models. In addition to %BF<sub>DXA</sub>, BMI was a significant predictor in all of the models. Age was only significant in the model at the endpoint. The corresponding percentages of variation for the difference between DXA and BIA based on %BF<sub>DXA</sub>, BMI, and age were 23.1%, 24.1%, and 20.7%, respectively. In females, %BF<sub>DXA</sub> was a significant predictor for &#x00394;%BF at the baseline, the endpoint, and in changes. The corresponding percentages of variation for the difference between DXA and BIA based on %BF<sub>DXA</sub> at the baseline, the endpoint, and in changes were 22.8%, 13.5%, and 9.4%, respectively. %BF<sub>DXA</sub> remained significant in all of the models when BMI and age were considered. In addition to %BF<sub>DXA</sub>, BMI was significant in all of the models. The corresponding percentages of variation for the differences between DXA and BIA based on %BF<sub>DXA</sub>, BMI, and age were 40.4%, 48.8%, and 25.4%, respectively.</p></sec></sec><sec id="s4"><title>Discussion</title><p>The current study showed that BIA is a useful measuring tool for the assessment of %BF at the endpoint in individuals with normal weight, overweight, or obesity, but provides less accurate predictions of %BF in changes during the weight-loss intervention programs. This result was demonstrated by the strong correlation between %BF parameters determined by BIA and DXA. Our Bland-Altman agreement analysis showed that BIA underestimated %BF. This bias increased as %BF<sub>DXA</sub> increased. The variation in percentage of this bias, which is associated with %BF<sub>DXA</sub>, was significantly higher in females than that in males. Therefore, caution should be used when interpreting the changes in %BF between the baseline and the endpoint when BIA is used in clinical practice, particularly in obese or overweight Chinese females.</p><p>Several studies have compared BIA with DXA as the reference method. However, results are mixed. In general, when assessing %BF in cross-sectional studies, some studies have reported that BIA overestimates %BF or fat mass weight <xref rid="pone.0058272-Shafer1" ref-type="bibr">[28]</xref>, <xref rid="pone.0058272-LloretLinares1" ref-type="bibr">[34]</xref>, <xref rid="pone.0058272-Kim1" ref-type="bibr">[36]</xref>, whereas others have revealed that BIA underestimates %BF or fat mass weight <xref rid="pone.0058272-Lazzer1" ref-type="bibr">[26]</xref>, <xref rid="pone.0058272-Newton1" ref-type="bibr">[27]</xref>, <xref rid="pone.0058272-Verdich1" ref-type="bibr">[30]</xref>, <xref rid="pone.0058272-NewtonJr1" ref-type="bibr">[33]</xref>, which is also found in the present study. Similarly, among these longitudinal studies, some have underestimated %BF at the baseline, at the endpoint, and in change, whereas some studies have overestimated %BF at different time points. However, results in previous studies are difficult to compare with those in the present study because various devices were used, such as foot-to-foot BIA <xref rid="pone.0058272-Lazzer1" ref-type="bibr">[26]</xref>, <xref rid="pone.0058272-LloretLinares1" ref-type="bibr">[34]</xref>, devices with adhesive tape <xref rid="pone.0058272-Lazzer1" ref-type="bibr">[26]</xref>, <xref rid="pone.0058272-Newton1" ref-type="bibr">[27]</xref>, <xref rid="pone.0058272-Verdich1" ref-type="bibr">[30]</xref>, <xref rid="pone.0058272-NewtonJr1" ref-type="bibr">[33]</xref>, <xref rid="pone.0058272-Aslam1" ref-type="bibr">[35]</xref>, <xref rid="pone.0058272-Kim1" ref-type="bibr">[36]</xref>, or multi-frequency devices <xref rid="pone.0058272-Shafer1" ref-type="bibr">[28]</xref>. Our results are in agreement with those in two cross-sectional studies, in which a BIA-type device, namely, the hand-to-foot BIA with simple frequency, was used. In particular, similar estimates of %BF have been reported <xref rid="pone.0058272-Sato1" ref-type="bibr">[29]</xref>, <xref rid="pone.0058272-Neovius1" ref-type="bibr">[32]</xref>. In one of these two studies, 72 obese Japanese adults (age &#x0200a;=&#x0200a;51.2&#x000b1;9.4 years; BMI &#x0200a;=&#x0200a;28.0&#x000b1;2.2 kg/m<sup>2</sup>) were considered, in which body fat at the extremities, trunk, and total body was determined using DXA and single-frequency BIA equipment (BC-118, Tanita Corp., Tokyo, Japan) <xref rid="pone.0058272-Sato1" ref-type="bibr">[29]</xref>. The accuracy of the estimated %BF value in the trunk was lower than that of the total body. SF-BIA reveals an underestimated %BF in the total body in males. In another study, Neovius et al. also examined the accuracy of SF-BIA (BC-418, Tanita Corp., Tokyo, Japan) in 136 obese Swedish women (age &#x0200a;=&#x0200a;48.1&#x000b1;7.7 years; BMI: 30.4&#x000b1;2.9 kg/m<sup>2</sup>) <xref rid="pone.0058272-Neovius1" ref-type="bibr">[32]</xref>. The BIA equipment used has revealed an underestimated %BF, which is consistent with our findings. Two possible reasons can explain this underestimated result. First, 50 kHz of current can pass through extracellular and intracellular spaces, and thus individual hydration states can be used as a factor of error. Second, the body position, particularly during standing, can change the fluid distribution, which can influence the measurement of resistance.</p><p>Our regression analysis indicated that a higher %BF<sub>DXA</sub> increased the biases between DXA and BIA at the baseline, the endpoint, and in changes in males and females, and a higher BMI decreased the biases, except BMI at the baseline in males. These results are consistent with those of Neovius et al. <xref rid="pone.0058272-Neovius1" ref-type="bibr">[32]</xref>, in which the variation in percentages for the differences between DXA and BIA based on %BF<sub>DXA</sub> was similar to that in our study at the baseline in females. However, Neovius only evaluated the performance of BIA compared with DXA in centrally obese women by using a cross-sectional study <xref rid="pone.0058272-Neovius1" ref-type="bibr">[32]</xref>. Our findings further revealed the changes in obese individuals during the intervention programs. The results in males and females with normal weight, overweight, or obesity were also reported. Our findings indicated that biases were significantly greater in females compared with those in males, which is attributed to the regional differences in the fat distribution in the body.</p><p>Few studies have investigated this issue in Asia. In addition to the findings in the previous Japanese report <xref rid="pone.0058272-Sato1" ref-type="bibr">[29]</xref>, a Korean longitudinal study compared the body composition assessments in terms of BIA and DXA before and after a six-week herbal diet intervention program in 50 pre-menopausal women (age &#x0200a;=&#x0200a;30.6&#x000b1;6.2 years; BMI &#x0200a;=&#x0200a;31.7&#x000b1;3.8 kg/m<sup>2</sup>) <xref rid="pone.0058272-Kim1" ref-type="bibr">[36]</xref>. In these two studies, <italic>r</italic> between %BF<sub>BIA</sub> and %BF<sub>DXA</sub> is significant <xref rid="pone.0058272-Sato1" ref-type="bibr">[29]</xref>, <xref rid="pone.0058272-Kim1" ref-type="bibr">[36]</xref>, which is consistent with our findings. However, <italic>r</italic> is slightly higher in Japanese (<italic>r</italic>&#x0003e;0.70, p&#x0003c;0.01) and Koreans before the six-week intervention (<italic>r</italic>&#x0200a;=&#x0200a;0.79, <italic>p</italic>&#x0003c;0.05) compared with that in our findings (<italic>r</italic>&#x0200a;=&#x0200a;0.64 at the baseline; <italic>r</italic>&#x0200a;=&#x0200a;0.71 at the endpoint, p&#x0003c;0.001) in the female group. Differences between BIA and DXA measurements were also observed in these two studies <xref rid="pone.0058272-Sato1" ref-type="bibr">[29]</xref>, <xref rid="pone.0058272-Kim1" ref-type="bibr">[36]</xref>. In our study, BIA underestimated %BF of the total body in both genders, but was only observed in males in the previous Japanese study <xref rid="pone.0058272-Sato1" ref-type="bibr">[29]</xref>. By contrast, BIA overestimated the total body fat by 2.54 kg and changes in %BF compared with DXA (p&#x0003c;0.001) in the Korean study <xref rid="pone.0058272-Kim1" ref-type="bibr">[36]</xref>. Thus, we need a larger sample size to obtain more accurate information in future studies for a better understanding of the differences between BIA and DXA.</p><p>The present study has both strengths and weaknesses. For the strengths, our sample size was larger compared with previous longitudinal studies or randomized control trials that having size of samples from 34 to 136. Due to the larger sample size, an evaluation stratified by genders was available in the present study. Our study also evaluated the accuracy of BIA among obese or overweight subjects, and the endpoint of the study allowed us to estimate the accuracy of BIA among subjects with normal weight, overweight, or obesity after participating in the weight-loss programs. The current study also described the subjects at different periods; thus, we can determine the accuracy of BIA in weight changes during the intervention programs.</p><p>The current study also has several limitations. The use of pencil-beam DXA as the gold standard was the first limitation because the device is an older generation of DXA instrument. A previous study compared the %BF measurements between pencil-beam and fan-beam DXA <xref rid="pone.0058272-Ellis1" ref-type="bibr">[41]</xref>. Results showed that the mean differences were &#x02013;0.7% for %fat and 6.4% for fat in kg, indicating that the two DXA technologies can be considered equivalent. We also used the same instrument in %BF during the entire intervention period, which prevented extra variations and minimized bias to evaluate the accuracy of BIA measurements. Second, we only studied Chinese adults. Ethnic- and age-related differences in the accuracy of BIA measurements likely exist. Studies of other ethnic groups, children, or adolescents may yield different results. Third, we did not include a severely obese group; we only tested the accuracy in the overall excess weight. Therefore, our results were limited to a severely obese cohort.</p><p>In conclusion, BIA is useful and relatively cheap equipment in the assessment of obesity in both genders. During the weight-loss program period, we found that BIA provides a valid estimate at the endpoint, particularly in individuals with normal weight, overweight, or obesity, but provides less accurate predictions of %BF at the baseline in obese individuals or in weight changes during the intervention programs. This study is the first to validate BIA in a randomized control trial of weight loss in Chinese subjects. Our findings indicate that BIA underestimated %BF. The difference between DXA and BIA is likely to increase as an individual's %BF<sub>DXA</sub> increases. Thus, this study should be replicated using other ethnic and age groups with a severely obese cohort.</p></sec></body><back><ref-list><title>References</title><ref id="pone.0058272-Kannel1"><label>1</label><mixed-citation publication-type="journal">
<name><surname>Kannel</surname><given-names>WB</given-names></name>, <name><surname>d'Agostino</surname><given-names>R</given-names></name>, <name><surname>Cobb</surname><given-names>JL</given-names></name> (<year>1996</year>) <article-title>Effect of weight on cardiovascular disease</article-title>. <source>Am J Clin Nutr</source>
<volume>63</volume>: <fpage>419S</fpage>&#x02013;<lpage>422S</lpage>.<pub-id pub-id-type="pmid">8615332</pub-id></mixed-citation></ref><ref id="pone.0058272-Carroll1"><label>2</label><mixed-citation publication-type="journal">
<name><surname>Carroll</surname><given-names>K</given-names></name> (<year>1998</year>) <article-title>Obesity as a risk factor for certain types of cancer</article-title>. <source>Lipids</source>
<volume>33</volume>: <fpage>1055</fpage>&#x02013;<lpage>1059</lpage>.<pub-id pub-id-type="pmid">9870899</pub-id></mixed-citation></ref><ref id="pone.0058272-Alberti1"><label>3</label><mixed-citation publication-type="journal">
<name><surname>Alberti</surname><given-names>K</given-names></name>, <name><surname>Zimmet</surname><given-names>P</given-names></name> (<year>1998</year>) <article-title>Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation</article-title>. <source>Diabet Med</source>
<volume>15</volume>: <fpage>539</fpage>&#x02013;<lpage>553</lpage>.<pub-id pub-id-type="pmid">9686693</pub-id></mixed-citation></ref><ref id="pone.0058272-Consultation1"><label>4</label><mixed-citation publication-type="other">Consultation W (2000) Obesity: preventing and managing the global epidemic. World Health Organ Tech Rep Ser 894: i-xii, 1&#x02013;253.</mixed-citation></ref><ref id="pone.0058272-Kuczmarski1"><label>5</label><mixed-citation publication-type="journal">
<name><surname>Kuczmarski</surname><given-names>RJ</given-names></name>, <name><surname>Flegal</surname><given-names>KM</given-names></name>, <name><surname>Campbell</surname><given-names>SM</given-names></name>, <name><surname>Johnson</surname><given-names>CL</given-names></name> (<year>1994</year>) <article-title>Increasing prevalence of overweight among US adults</article-title>. <source>JAMA</source>
<volume>272</volume>: <fpage>205</fpage>&#x02013;<lpage>211</lpage>.<pub-id pub-id-type="pmid">8022039</pub-id></mixed-citation></ref><ref id="pone.0058272-Seidell1"><label>6</label><mixed-citation publication-type="journal">
<name><surname>Seidell</surname><given-names>JC</given-names></name>, <name><surname>Verschuren</surname><given-names>W</given-names></name>, <name><surname>van Leer</surname><given-names>EM</given-names></name>, <name><surname>Kromhout</surname><given-names>D</given-names></name> (<year>1996</year>) <article-title>Overweight, underweight, and mortality: a prospective study of 48287 men and women</article-title>. <source>Arch Intern Med</source>
<volume>156</volume>: <fpage>958</fpage>&#x02013;<lpage>963</lpage>.<pub-id pub-id-type="pmid">8624176</pub-id></mixed-citation></ref><ref id="pone.0058272-Chu1"><label>7</label><mixed-citation publication-type="journal">
<name><surname>Chu</surname><given-names>NF</given-names></name> (<year>2005</year>) <article-title>Prevalence of obesity in Taiwan</article-title>. <source>Obes Rev</source>
<volume>6</volume>: <fpage>271</fpage>&#x02013;<lpage>274</lpage>.<pub-id pub-id-type="pmid">16246212</pub-id></mixed-citation></ref><ref id="pone.0058272-Must1"><label>8</label><mixed-citation publication-type="journal">
<name><surname>Must</surname><given-names>A</given-names></name>, <name><surname>Spadano</surname><given-names>J</given-names></name>, <name><surname>Coakley</surname><given-names>EH</given-names></name>, <name><surname>Field</surname><given-names>AE</given-names></name>, <name><surname>Colditz</surname><given-names>G</given-names></name>, <etal>et al</etal> (<year>1999</year>) <article-title>The disease burden associated with overweight and obesity</article-title>. <source>JAMA</source>
<volume>282</volume>: <fpage>1523</fpage>&#x02013;<lpage>1529</lpage>.<pub-id pub-id-type="pmid">10546691</pub-id></mixed-citation></ref><ref id="pone.0058272-Kopelman1"><label>9</label><mixed-citation publication-type="journal">
<name><surname>Kopelman</surname><given-names>PG</given-names></name> (<year>2000</year>) <article-title>Obesity as a medical problem</article-title>. <source>Nature</source>
<volume>404</volume>: <fpage>635</fpage>&#x02013;<lpage>643</lpage>.<pub-id pub-id-type="pmid">10766250</pub-id></mixed-citation></ref><ref id="pone.0058272-Deurenberg1"><label>10</label><mixed-citation publication-type="journal">
<name><surname>Deurenberg</surname><given-names>P</given-names></name>, <name><surname>Van der Kooy</surname><given-names>K</given-names></name>, <name><surname>Leenen</surname><given-names>R</given-names></name>, <name><surname>Weststrate</surname><given-names>J</given-names></name>, <name><surname>Seidell</surname><given-names>J</given-names></name> (<year>1991</year>) <article-title>Sex and age specific prediction formulas for estimating body composition from bioelectrical impedance: a cross-validation study</article-title>. <source>Int J Obes</source>
<volume>15</volume>: <fpage>17</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="pmid">2010255</pub-id></mixed-citation></ref><ref id="pone.0058272-Houtkooper1"><label>11</label><mixed-citation publication-type="journal">
<name><surname>Houtkooper</surname><given-names>LB</given-names></name>, <name><surname>Lohman</surname><given-names>TG</given-names></name>, <name><surname>Going</surname><given-names>SB</given-names></name>, <name><surname>Howell</surname><given-names>WH</given-names></name> (<year>1996</year>) <article-title>Why bioelectrical impedance analysis should be used for estimating adiposity</article-title>. <source>Am J Clin Nutr</source>
<volume>64</volume>: <fpage>436S</fpage>&#x02013;<lpage>448S</lpage>.<pub-id pub-id-type="pmid">8780360</pub-id></mixed-citation></ref><ref id="pone.0058272-Roubenoff1"><label>12</label><mixed-citation publication-type="journal">
<name><surname>Roubenoff</surname><given-names>R</given-names></name> (<year>1996</year>) <article-title>Applications of bioelectrical impedance analysis for body composition to epidemiologic studies</article-title>. <source>Am J Clin Nutr</source>
<volume>64</volume>: <fpage>459S</fpage>&#x02013;<lpage>462S</lpage>.<pub-id pub-id-type="pmid">8780363</pub-id></mixed-citation></ref><ref id="pone.0058272-Yamauchi1"><label>13</label><mixed-citation publication-type="journal">
<name><surname>Yamauchi</surname><given-names>T</given-names></name>, <name><surname>Kamon</surname><given-names>J</given-names></name>, <name><surname>Minokoshi</surname><given-names>Y</given-names></name>, <name><surname>Ito</surname><given-names>Y</given-names></name>, <name><surname>Waki</surname><given-names>H</given-names></name>, <etal>et al</etal> (<year>2002</year>) <article-title>Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase</article-title>. <source>Nat Med</source>
<volume>8</volume>: <fpage>1288</fpage>&#x02013;<lpage>1295</lpage>.<pub-id pub-id-type="pmid">12368907</pub-id></mixed-citation></ref><ref id="pone.0058272-Yokota1"><label>14</label><mixed-citation publication-type="journal">
<name><surname>Yokota</surname><given-names>T</given-names></name>, <name><surname>Oritani</surname><given-names>K</given-names></name>, <name><surname>Takahashi</surname><given-names>I</given-names></name>, <name><surname>Ishikawa</surname><given-names>J</given-names></name>, <name><surname>Matsuyama</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2000</year>) <article-title>Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages</article-title>. <source>Blood</source>
<volume>96</volume>: <fpage>1723</fpage>&#x02013;<lpage>1732</lpage>.<pub-id pub-id-type="pmid">10961870</pub-id></mixed-citation></ref><ref id="pone.0058272-Staiger1"><label>15</label><mixed-citation publication-type="journal">
<name><surname>Staiger</surname><given-names>H</given-names></name>, <name><surname>Tschritter</surname><given-names>O</given-names></name>, <name><surname>Machann</surname><given-names>J</given-names></name>, <name><surname>Thamer</surname><given-names>C</given-names></name>, <name><surname>Fritsche</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2003</year>) <article-title>Relationship of serum adiponectin and leptin concentrations with body fat distribution in humans</article-title>. <source>Obes Res</source>
<volume>11</volume>: <fpage>368</fpage>&#x02013;<lpage>372</lpage>.<pub-id pub-id-type="pmid">12634431</pub-id></mixed-citation></ref><ref id="pone.0058272-Festen1"><label>16</label><mixed-citation publication-type="journal">
<name><surname>Festen</surname><given-names>DA</given-names></name>, <name><surname>van Toorenenbergen</surname><given-names>A</given-names></name>, <name><surname>Duivenvoorden</surname><given-names>HJ</given-names></name>, <name><surname>Hokken-Koelega</surname><given-names>AC</given-names></name> (<year>2007</year>) <article-title>Adiponectin levels in prepubertal children with Prader-Willi syndrome before and during growth hormone therapy</article-title>. <source>J Clin Endocrinol Metab</source>
<volume>92</volume>: <fpage>1549</fpage>&#x02013;<lpage>1554</lpage>.<pub-id pub-id-type="pmid">17264186</pub-id></mixed-citation></ref><ref id="pone.0058272-GmezAmbrosi1"><label>17</label><mixed-citation publication-type="journal">
<name><surname>G&#x000f3;mez-Ambrosi</surname><given-names>J</given-names></name>, <name><surname>Silva</surname><given-names>C</given-names></name>, <name><surname>Galofr&#x000e9;</surname><given-names>JC</given-names></name>, <name><surname>Escalada</surname><given-names>J</given-names></name>, <name><surname>Santos</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Body adiposity and type 2 diabetes: increased risk with a high body fat percentage even having a normal BMI</article-title>. <source>Obesity</source>
<volume>19</volume>: <fpage>1439</fpage>&#x02013;<lpage>1444</lpage>.<pub-id pub-id-type="pmid">21394093</pub-id></mixed-citation></ref><ref id="pone.0058272-Shea1"><label>18</label><mixed-citation publication-type="journal">
<name><surname>Shea</surname><given-names>JL</given-names></name>, <name><surname>King</surname><given-names>MT</given-names></name>, <name><surname>Yi</surname><given-names>Y</given-names></name>, <name><surname>Gulliver</surname><given-names>W</given-names></name>, <name><surname>Sun</surname><given-names>G</given-names></name> (<year>2012</year>) <article-title>Body fat percentage is associated with cardiometabolic dysregulation in BMI-defined normal weight subjects</article-title>. <source>Nutr Metab Cardiovasc Dis</source>
<volume>22</volume>: <fpage>741</fpage>&#x02013;<lpage>747</lpage>.<pub-id pub-id-type="pmid">21215604</pub-id></mixed-citation></ref><ref id="pone.0058272-Yamashita1"><label>19</label><mixed-citation publication-type="journal">
<name><surname>Yamashita</surname><given-names>K</given-names></name>, <name><surname>Kondo</surname><given-names>T</given-names></name>, <name><surname>Osugi</surname><given-names>S</given-names></name>, <name><surname>Shimokata</surname><given-names>K</given-names></name>, <name><surname>Maeda</surname><given-names>K</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>The Significance of Measuring Body Fat Percentage Determined by Bioelectrical Impedance Analysis for Detecting Subjects with Cardiovascular Disease Risk Factors</article-title>. <source>Circ J</source>
<volume>76</volume>: <fpage>2435</fpage>&#x02013;<lpage>2442</lpage>.<pub-id pub-id-type="pmid">22784998</pub-id></mixed-citation></ref><ref id="pone.0058272-Dee1"><label>20</label><mixed-citation publication-type="journal">
<name><surname>Dee</surname><given-names>A</given-names></name>, <name><surname>McKean-Cowdin</surname><given-names>R</given-names></name>, <name><surname>Neuhouser</surname><given-names>ML</given-names></name>, <name><surname>Ulrich</surname><given-names>C</given-names></name>, <name><surname>Baumgartner</surname><given-names>RN</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>DEXA measures of body fat percentage and acute phase proteins among breast cancer survivors: a Cross-Sectional Analysis</article-title>. <source>BMC Cancer</source>
<volume>12</volume>: <fpage>343</fpage>.<pub-id pub-id-type="pmid">22873489</pub-id></mixed-citation></ref><ref id="pone.0058272-Evans1"><label>21</label><mixed-citation publication-type="journal">
<name><surname>Evans</surname><given-names>EM</given-names></name>, <name><surname>Misic</surname><given-names>MM</given-names></name>, <name><surname>Mallard</surname><given-names>DM</given-names></name> (<year>2010</year>) <article-title>A technique to assess body composition and sarcopenia using DXA: application for an obese population</article-title>. <source>Eur J Clin Nutr</source>
<volume>64</volume>: <fpage>218</fpage>&#x02013;<lpage>220</lpage>.<pub-id pub-id-type="pmid">19904294</pub-id></mixed-citation></ref><ref id="pone.0058272-DeSchepper1"><label>22</label><mixed-citation publication-type="journal">
<name><surname>De Schepper</surname><given-names>J</given-names></name>, <name><surname>Roggen</surname><given-names>I</given-names></name>, <name><surname>Van Biervliet</surname><given-names>S</given-names></name>, <name><surname>Robberecht</surname><given-names>E</given-names></name>, <name><surname>Gies</surname><given-names>I</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Comparative bone status assessment by dual energy X-ray absorptiometry, peripheral quantitative computed tomography and quantitative ultrasound in adolescents and young adults with cystic fibrosis</article-title>. <source>J Cyst Fibros</source>
<volume>11</volume>: <fpage>119</fpage>&#x02013;<lpage>124</lpage>.<pub-id pub-id-type="pmid">22119452</pub-id></mixed-citation></ref><ref id="pone.0058272-Liu1"><label>23</label><mixed-citation publication-type="journal">
<name><surname>Liu</surname><given-names>CR</given-names></name>, <name><surname>Niu</surname><given-names>HJ</given-names></name>, <name><surname>Pu</surname><given-names>F</given-names></name>, <name><surname>Wang</surname><given-names>L</given-names></name>, <name><surname>Sun</surname><given-names>LW</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>The effect of physical loading on calcaneus quantitative ultrasound measurement: a cross-section study</article-title>. <source>BMC musculoskel dis</source>
<volume>13</volume>: <fpage>70</fpage>.</mixed-citation></ref><ref id="pone.0058272-Xu1"><label>24</label><mixed-citation publication-type="journal">
<name><surname>Xu</surname><given-names>B</given-names></name>, <name><surname>Yu</surname><given-names>W</given-names></name>, <name><surname>Yao</surname><given-names>M</given-names></name>, <name><surname>Yao</surname><given-names>X</given-names></name>, <name><surname>Li</surname><given-names>Q</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>A 3D surface imaging system for assessing human obesity</article-title>. <source>SPIE</source>
<volume>7443</volume>: <fpage>74431U</fpage>&#x02013;<lpage>12</lpage>.</mixed-citation></ref><ref id="pone.0058272-Erceg1"><label>25</label><mixed-citation publication-type="journal">
<name><surname>Erceg</surname><given-names>DN</given-names></name>, <name><surname>Dieli-Conwright</surname><given-names>CM</given-names></name>, <name><surname>Rossuello</surname><given-names>AE</given-names></name>, <name><surname>Jensky</surname><given-names>NE</given-names></name>, <name><surname>Sun</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>The Stayhealthy bioelectrical impedance analyzer predicts body fat in children and adults</article-title>. <source>Nutr Res</source>
<volume>30</volume>: <fpage>297</fpage>&#x02013;<lpage>304</lpage>.<pub-id pub-id-type="pmid">20579521</pub-id></mixed-citation></ref><ref id="pone.0058272-Lazzer1"><label>26</label><mixed-citation publication-type="journal">
<name><surname>Lazzer</surname><given-names>S</given-names></name>, <name><surname>Boirie</surname><given-names>Y</given-names></name>, <name><surname>Meyer</surname><given-names>M</given-names></name>, <name><surname>Vermorel</surname><given-names>M</given-names></name> (<year>2003</year>) <article-title>Evaluation of two foot-to-foot bioelectrical impedance analysers to assess body composition in overweight and obese adolescents</article-title>. <source>Br J Nutr</source>
<volume>90</volume>: <fpage>987</fpage>&#x02013;<lpage>992</lpage>.<pub-id pub-id-type="pmid">14667192</pub-id></mixed-citation></ref><ref id="pone.0058272-Newton1"><label>27</label><mixed-citation publication-type="journal">
<name><surname>Newton</surname><given-names>R</given-names></name>, <name><surname>Alfonso</surname><given-names>A</given-names></name>, <name><surname>White</surname><given-names>M</given-names></name>, <name><surname>York-Crowe</surname><given-names>E</given-names></name>, <name><surname>Walden</surname><given-names>H</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>Percent body fat measured by BIA and DEXA in obese, African-American adolescent girls</article-title>. <source>Int J Obes</source>
<volume>29</volume>: <fpage>594</fpage>&#x02013;<lpage>602</lpage>.</mixed-citation></ref><ref id="pone.0058272-Shafer1"><label>28</label><mixed-citation publication-type="journal">
<name><surname>Shafer</surname><given-names>KJ</given-names></name>, <name><surname>Siders</surname><given-names>WA</given-names></name>, <name><surname>Johnson</surname><given-names>LAK</given-names></name>, <name><surname>Lukaski</surname><given-names>HC</given-names></name> (<year>2009</year>) <article-title>Validity of segmental multiple-frequency bioelectrical impedance analysis to estimate body composition of adults across a range of body mass indexes</article-title>. <source>Nutrition</source>
<volume>25</volume>: <fpage>25</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="pmid">18723322</pub-id></mixed-citation></ref><ref id="pone.0058272-Sato1"><label>29</label><mixed-citation publication-type="journal">
<name><surname>Sato</surname><given-names>S</given-names></name>, <name><surname>Demura</surname><given-names>S</given-names></name>, <name><surname>Kitabayashi</surname><given-names>T</given-names></name>, <name><surname>Noguchi</surname><given-names>T</given-names></name> (<year>2007</year>) <article-title>Segmental body composition assessment for obese Japanese adults by single-frequency bioelectrical impedance analysis with 8-point contact electrodes</article-title>. <source>J Physiol Anthropol</source>
<volume>26</volume>: <fpage>533</fpage>&#x02013;<lpage>540</lpage>.<pub-id pub-id-type="pmid">18092509</pub-id></mixed-citation></ref><ref id="pone.0058272-Verdich1"><label>30</label><mixed-citation publication-type="journal">
<name><surname>Verdich</surname><given-names>C</given-names></name>, <name><surname>Barbe</surname><given-names>P</given-names></name>, <name><surname>Petersen</surname><given-names>M</given-names></name>, <name><surname>Grau</surname><given-names>K</given-names></name>, <name><surname>Ward</surname><given-names>L</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Changes in body composition during weight loss in obese subjects in the NUGENOB study: Comparison of bioelectrical impedance vs. dual-energy X-ray absorptiometry</article-title>. <source>Diabetes Metab</source>
<volume>37</volume>: <fpage>222</fpage>&#x02013;<lpage>229</lpage>.<pub-id pub-id-type="pmid">21236715</pub-id></mixed-citation></ref><ref id="pone.0058272-BosyWestphal1"><label>31</label><mixed-citation publication-type="journal">
<name><surname>Bosy-Westphal</surname><given-names>A</given-names></name>, <name><surname>Later</surname><given-names>W</given-names></name>, <name><surname>Hitze</surname><given-names>B</given-names></name>, <name><surname>Sato</surname><given-names>T</given-names></name>, <name><surname>Kossel</surname><given-names>E</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Accuracy of bioelectrical impedance consumer devices for measurement of body composition in comparison to whole body magnetic resonance imaging and dual X-ray absorptiometry</article-title>. <source>Obes Facts</source>
<volume>1</volume>: <fpage>319</fpage>&#x02013;<lpage>324</lpage>.<pub-id pub-id-type="pmid">20054195</pub-id></mixed-citation></ref><ref id="pone.0058272-Neovius1"><label>32</label><mixed-citation publication-type="journal">
<name><surname>Neovius</surname><given-names>M</given-names></name>, <name><surname>Hemmingsson</surname><given-names>E</given-names></name>, <name><surname>Freyschuss</surname><given-names>B</given-names></name>, <name><surname>Udd&#x000e9;n</surname><given-names>J</given-names></name> (<year>2006</year>) <article-title>Bioelectrical Impedance Underestimates Total and Truncal Fatness in Abdominally Obese Women</article-title>. <source>Obesity</source>
<volume>14</volume>: <fpage>1731</fpage>&#x02013;<lpage>1738</lpage>.<pub-id pub-id-type="pmid">17062802</pub-id></mixed-citation></ref><ref id="pone.0058272-NewtonJr1"><label>33</label><mixed-citation publication-type="journal">
<name><surname>Newton Jr</surname><given-names>R</given-names></name>, <name><surname>Alfonso</surname><given-names>A</given-names></name>, <name><surname>York-Crowe</surname><given-names>E</given-names></name>, <name><surname>Walden</surname><given-names>H</given-names></name>, <name><surname>White</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Comparison of body composition methods in obese African-American women</article-title>. <source>Obesity (Silver Spring)</source>
<volume>14</volume>: <fpage>415</fpage>&#x02013;<lpage>422</lpage>.<pub-id pub-id-type="pmid">16648612</pub-id></mixed-citation></ref><ref id="pone.0058272-LloretLinares1"><label>34</label><mixed-citation publication-type="journal">
<name><surname>Lloret Linares</surname><given-names>C</given-names></name>, <name><surname>Ciangura</surname><given-names>C</given-names></name>, <name><surname>Bouillot</surname><given-names>JL</given-names></name>, <name><surname>Coupaye</surname><given-names>M</given-names></name>, <name><surname>Decl&#x000e8;ves</surname><given-names>X</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Validity of Leg-to-Leg Bioelectrical Impedance Analysis to Estimate Body Fat in Obesity</article-title>. <source>Obes Surg</source>
<volume>21</volume>: <fpage>1</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">20012226</pub-id></mixed-citation></ref><ref id="pone.0058272-Aslam1"><label>35</label><mixed-citation publication-type="journal">
<name><surname>Aslam</surname><given-names>M</given-names></name>, <name><surname>Eckhauser</surname><given-names>AW</given-names></name>, <name><surname>Dorminy</surname><given-names>CA</given-names></name>, <name><surname>Dossett</surname><given-names>CM</given-names></name>, <name><surname>Choi</surname><given-names>L</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Assessing body fat changes during moderate weight loss with anthropometry and bioelectrical impedance</article-title>. <source>Obes Res Clin Pract</source>
<volume>3</volume>: <fpage>209</fpage>&#x02013;<lpage>219</lpage>.<pub-id pub-id-type="pmid">20161645</pub-id></mixed-citation></ref><ref id="pone.0058272-Kim1"><label>36</label><mixed-citation publication-type="journal">
<name><surname>Kim</surname><given-names>H</given-names></name>, <name><surname>Gallagher</surname><given-names>D</given-names></name>, <name><surname>Song</surname><given-names>M</given-names></name> (<year>2005</year>) <article-title>Comparison of body composition methods during weight loss in obese women using herbal formula</article-title>. <source>Am J Chin Med</source>
<volume>33</volume>: <fpage>851</fpage>&#x02013;<lpage>858</lpage>.<pub-id pub-id-type="pmid">16355441</pub-id></mixed-citation></ref><ref id="pone.0058272-Frisard1"><label>37</label><mixed-citation publication-type="journal">
<name><surname>Frisard</surname><given-names>M</given-names></name>, <name><surname>Greenway</surname><given-names>F</given-names></name>, <name><surname>Delany</surname><given-names>J</given-names></name> (<year>2005</year>) <article-title>Comparison of methods to assess body composition changes during a period of weight loss</article-title>. <source>Obes Res</source>
<volume>13</volume>: <fpage>845</fpage>&#x02013;<lpage>854</lpage>.<pub-id pub-id-type="pmid">15919837</pub-id></mixed-citation></ref><ref id="pone.0058272-Department1"><label>38</label><mixed-citation publication-type="other">Department of Health, Executive Yuan, R.O.C. (2002) The definition of obesity and intervention principles toward compatriots. Aug. 09. Available at: <ext-link ext-link-type="uri" xlink:href="http://www.doh.gov.tw/CHT2006/DM/DM2_p01.aspx?class_no=25&#x00026;now_fod_list_no=3942&#x00026;level_no=2&#x00026;doc_no=32">http://www.doh.gov.tw/CHT2006/DM/DM2_p01.aspx?class_no=25&#x00026;now_fod_list_no=3942&#x00026;level_no=2&#x00026;doc_no=32</ext-link> Accessed 09 November 2012.</mixed-citation></ref><ref id="pone.0058272-Crepaldi1"><label>39</label><mixed-citation publication-type="journal">
<name><surname>Crepaldi</surname><given-names>G</given-names></name>, <name><surname>Maggi</surname><given-names>S</given-names></name> (<year>2006</year>) <article-title>The metabolic syndrome: a historical context</article-title>. <source>Diabetes voice</source>
<volume>51</volume>: <fpage>8</fpage>&#x02013;<lpage>10</lpage>.</mixed-citation></ref><ref id="pone.0058272-Taylor1"><label>40</label><mixed-citation publication-type="journal">
<name><surname>Taylor</surname><given-names>R</given-names></name> (<year>1990</year>) <article-title>Interpretation of the correlation coefficient: a basic review</article-title>. <source>JDMS</source>
<volume>6</volume>: <fpage>35</fpage>&#x02013;<lpage>39</lpage>.</mixed-citation></ref><ref id="pone.0058272-Ellis1"><label>41</label><mixed-citation publication-type="journal">
<name><surname>Ellis</surname><given-names>K</given-names></name>, <name><surname>Shypailo</surname><given-names>R</given-names></name> (<year>1998</year>) <article-title>Bone mineral and body composition measurements: cross-calibration of pencil-beam and fan-beam dual-energy X-ray absorptiometers</article-title>. <source>J Bone Miner Res</source>
<volume>13</volume>: <fpage>1613</fpage>&#x02013;<lpage>1618</lpage>.<pub-id pub-id-type="pmid">9783550</pub-id></mixed-citation></ref></ref-list></back></article>